A population-based study of pediatric anaplastic large cell lymphoma

Cancer

Volumn 94, Issue 6, 2002, Pages 1830-1835

  Alessandri, Angela J ^a   Pritchard, Sheila L ^a   Schultz, Kirk R ^a   Massing, Bonnie G ^b  

^a BC CHILDREN S HOSPITAL   (Canada)

^b CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

Anaplastic large cell lymphoma; Childhood; Incidence; Non Hodgkin lymphoma

Indexed keywords

ADOLESCENT; ANAPLASTIC LARGE CELL LYMPHOMA; ARTICLE; CANADA; CANCER INCIDENCE; CANCER STAGING; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; ETHNIC GROUP; HUMAN; IMMUNOHISTOLOGY; LARGE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; ONSET AGE; POPULATION RESEARCH; PRIORITY JOURNAL;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRITISH COLUMBIA; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; EPIDEMIOLOGIC STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFANT; INFANT, NEWBORN; LYMPHOMA, LARGE-CELL; MALE; PROGNOSIS; TREATMENT OUTCOME;

EID: 0037086469     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10396     Document Type: Article

References (42)

1. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells
2. Pediatric lymphomas: Recent advances and commentary, on Ki-1 positive anaplastic large-cell lymphomas of childhood
3. Childhood non-Hodgkin's lymphomas in the United Kingdom: Findings from the UK Children's Cancer study
4. A revised EuropeanAmerican classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
5. Coexpression of epithelial membrane antigen (EMA), Ki-1 and interleukin-2 receptor by anaplastic large cell lymphomas: Diagnostic value in so-called malignant histiocytosis
6. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (Ki-1 lymphoma)
7. A novel translocation t(2;5) (p25;q35) in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis
8. CD30-positive large cell lymphomas (Ki-1 lymphoma) are associated with a chromosomal translocation involving 5q35
9. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma
10. Characterization of the transforming activity of p80 a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)
11. Role of nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma associated NPM-anaplastic kinase fusion protein in oncogenesis
12. Retrovirus mediated transfer of the NPM-ALK causes lymphoid malignancy in mice
13. Diagnosis of t(2;5) (p25;q35)-associated Ki-1 lymphoma with immunohistochemistry
14. Detection of ALK and NPM-ALK protein in normal and neoplastic cells with the monoclonal antibody ALK 1
15. Incidence of non-Hodgkin's lymphoma in children between 1970 and 1990 in nine European countries
16. Childhood NHL in Switzerland: Incidence and survival of 120 study and 42 non-study patients
17. Childhood non-Hodgkin's lymphoma in the five Nordic countries
18. Patterns and temporal trends in the incidence of malignant disease in children. I. Leukemia, lymphoma
19. Malignant lymphomas in children in the Netherlands in the period 1973-1985: Incidence in relation to leukemia: A report from the Dutch childhood leukemia study group
20. Non-Hodgkin lymphoma in children: A 20-year populationbased epidemiologic study in Western Sweden
21. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy
22. Clinical features of 31 patients with anaplastic large cell lymphoma
23. Clinical features and treatment outcome for children with CD30+ large cell non-Hodgkin's lymphoma
24. CD30+ anaplastic large-cell lymphoma in children: Analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology
25. Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster Group studies
26. Ki-1 (CD 30) anaplastic large-cell lymphoma in children
27. Large cell non-Hodgkin lymphoma of childhood: Analysis of 78 consecutive patients enrolled in 2 consecutive protocols at the Memorial Sloan-Kettering Cancer Center
28. The National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: Summary and description of working formulation for clinical usage
29. Childhood anaplastic large cell lymphoma Ki-1/CD30: Clinicopathologic features of 19 cases
30. NPM/ALK: A distinct clinicopathologic entity
31. High incidence of the t(2;5) (p25;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and the P-80 immunostaining
32. NPM/ALK and absence of Epstein-Barr virus
33. Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood
34. Clinicopathologic, cytogenetic and molecular studies of 13 Chinese patients with Ki-1 anaplastic large cell lymphoma. Special emphasis on the tumor response to 13-cis retinoic acid
35. Characteristics and prognosis of Ki-1 positive anaplastic large cell lymphoma in Asians
36. International variations in the incidence of childhood lymphomas
37. Non-Hodgkin's lymphoma in Asia
38. The incidence of non-Hodgkin's lymphoma and its histologic subtypes in Asian migrants to the United States and their descendents
39. Central nervous system involvement at diagnosis in a case of pediatric CD30+ anaplastic large cell lymphoma
40. Primary anaplastic large cell lymphoma of the central nervous system
41. Anaplastic large cell lymphoma (Ki-1/CD30+) in childhood